CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 200.65
-1.39 (-0.69%)
Nov 9, 2026, 12:20 PM AEDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 96.09 billion as of November 6, 2026. It is the 362nd most valuable company in the world and the 6th biggest in Australia. Its market cap has increased by 11.05% in one year.
Market Cap
96.09B
Enterprise Value
111.84B
Revenue
22.83B
Global Rank
Country Rank
#6 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 96.09B, an increase of 30,699.57%. That is a compound annual growth rate of 19.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 96.09B | 15.44% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.64B |
| Neuren Pharmaceuticals | 2.95B |
| Mesoblast | 2.64B |
| PYC Therapeutics | 1.85B |
| Clarity Pharmaceuticals | 557.76M |
| Clinuvel Pharmaceuticals | 379.22M |
| Tetratherix | 307.74M |
| Racura Oncology | 289.20M |